Key result
Doxorubicin treatment can result in biopsy-proven cardiotoxicity manifesting after a long latency period of seven years.
Answers are grounded in this paper and cite their sources.
Highlights the potential for a long latency period (up to 7 years) before the manifestation of doxorubicin-induced cardiotoxicity.
This report describes a patient treated for lymphoma who had development of doxorubicin (Adriamycin) cardiotoxicity proved by endomyocardial biopsy seven years after treatment. Doxorubicin cardiotoxicity is reviewed with emphasis on the implications of the long latency period for anthracycline cardiotoxicity in patients treated with this widely used antineoplastic agent.
No takes yet. Share an insight, caveat, or question.
Freter et al. (1986) studied this question. Doxorubicin treatment can result in biopsy-proven cardiotoxicity manifesting after a long latency period of seven years.
Synapse has enriched 10 related papers. Consider them for comparative context: